MX2008001151A - Proceso para la preparacion de perindopril cristalino. - Google Patents

Proceso para la preparacion de perindopril cristalino.

Info

Publication number
MX2008001151A
MX2008001151A MX2008001151A MX2008001151A MX2008001151A MX 2008001151 A MX2008001151 A MX 2008001151A MX 2008001151 A MX2008001151 A MX 2008001151A MX 2008001151 A MX2008001151 A MX 2008001151A MX 2008001151 A MX2008001151 A MX 2008001151A
Authority
MX
Mexico
Prior art keywords
preparation
perindopril
crystalline perindopril
crystalline
relates
Prior art date
Application number
MX2008001151A
Other languages
English (en)
Inventor
Anton Copar
Branko Jenko
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Publication of MX2008001151A publication Critical patent/MX2008001151A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se refiere a un nuevo proceso para la preparacion del perindopril cristalino. La presente invencion tambien se refiere a nuevas sales de alquil amonio de perindopril y los procesos para la preparacion de las mismas.
MX2008001151A 2005-07-25 2006-07-24 Proceso para la preparacion de perindopril cristalino. MX2008001151A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200500214 2005-07-25
PCT/EP2006/007258 WO2007017087A1 (en) 2005-07-25 2006-07-24 Process for the preparation of crystalline perindopril

Publications (1)

Publication Number Publication Date
MX2008001151A true MX2008001151A (es) 2008-03-13

Family

ID=37451139

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008001151A MX2008001151A (es) 2005-07-25 2006-07-24 Proceso para la preparacion de perindopril cristalino.

Country Status (14)

Country Link
US (1) US7923570B2 (es)
EP (1) EP1910287B1 (es)
JP (1) JP4972643B2 (es)
CN (1) CN101228126B (es)
AT (1) ATE549315T1 (es)
AU (1) AU2006278866B2 (es)
BR (1) BRPI0613976A2 (es)
CA (1) CA2615691C (es)
EA (1) EA013018B1 (es)
MX (1) MX2008001151A (es)
SI (1) SI1910287T1 (es)
UA (1) UA92752C2 (es)
WO (1) WO2007017087A1 (es)
ZA (1) ZA200800138B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100016614A1 (en) * 2005-08-12 2010-01-21 Lek Pharmaceuticals D.D Process for the preparation of perindopril erbumine
AU2006281681A1 (en) * 2005-08-12 2007-02-22 Sandoz Ag New crystalline form of perindopril erbumine
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
GB0910692D0 (en) 2009-06-20 2009-08-05 Teva Pharma Compound
CN111116709B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种培哚普利制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
AU2003263584A1 (en) * 2003-08-21 2005-03-10 Hetero Drugs Limited Process for pure perindopril tert-butylamine salt
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia

Also Published As

Publication number Publication date
WO2007017087A1 (en) 2007-02-15
CN101228126B (zh) 2011-10-19
ATE549315T1 (de) 2012-03-15
JP2009502833A (ja) 2009-01-29
BRPI0613976A2 (pt) 2011-02-22
US7923570B2 (en) 2011-04-12
EA013018B1 (ru) 2010-02-26
AU2006278866A1 (en) 2007-02-15
JP4972643B2 (ja) 2012-07-11
CA2615691C (en) 2015-11-10
AU2006278866B2 (en) 2012-03-15
ZA200800138B (en) 2009-08-26
CA2615691A1 (en) 2007-02-15
EA200800200A1 (ru) 2008-06-30
CN101228126A (zh) 2008-07-23
SI1910287T1 (sl) 2012-09-28
UA92752C2 (ru) 2010-12-10
EP1910287A1 (en) 2008-04-16
EP1910287B1 (en) 2012-03-14
US20080306135A1 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
MX2010002836A (es) Bortezomib y proceso para la produccion del mismo.
MY148253A (en) Azaadamantane derivatives and methods of use
UA93531C2 (en) Novel hydrogen sulfate salt
PH12013502448A1 (en) Processes and intermediates for making sweet taste enhancers
MY147732A (en) Process for the preparation of 2-substituted-5- (1-alkylthio) alkylpyridines
WO2006113509A3 (en) Quinobenzoxazine analogs and methods of using thereof
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
RS70904A (en) Process for preparing indolinone derivatives
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
MY146084A (en) Benzyl amines, a process for their production and their use as anti-inflammatory agents
TW200728310A (en) Process for the preparation of ferri-succinylcasein
TW200420541A (en) Crystalline forms
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
EA200870038A1 (ru) Способ получения аминов
TW200612959A (en) Method for preparing hydroxamic acids
TW200635905A (en) Processes for producing 4-aminoquinazolines
ZA200800138B (en) Process for the preparation of crystalline perindopril
TW200637832A (en) Process for preparing amorphous valsartan
TW200719889A (en) Amino acid derivatives
UA91733C2 (ru) Способ получения кристаллической формы орлистата
IL183271A0 (en) Crystalline form of cefdinir ammonium salt as an intermediate for the preparation of pure cefdinir
MX2008002066A (es) Neuva forma cristalina de perindopril-erbumina.
MX2007013872A (es) Procedimiento para la produccion de 4-bifenililazetidina-2-onas.
SG160353A1 (en) Process for the preparation of substituted benzoxazole compounds
UA102816C2 (ru) Способ синтеза кристаллической формы v агомелатина

Legal Events

Date Code Title Description
FG Grant or registration